Northwest Biotherapeutics reported $238.6M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.11B 307M Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Northwest Biotherapeutics USD 270M 86M Jun/2026
Pfizer USD 153.81B 12.24B Mar/2026
Plus Therapeutics USD 71M 19M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025